NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)
| CAPS Rating |
|
|---|
NPSP
VS S&P 500 (SPY)
NPSP News and Commentary
- Looking For Solid Science in Biotech – Blogs @ The Motley Fool
- Columbia Labs Fails to Impress FDA – Blogs @ The Motley Fool
- Rare Disease Drug Maker NPS Pharmaceuticals Looks Undervalued – Minyanville
- Is NPS Pharmaceuticals Hiding Weakness? – The Motley Fool
- NPS Pharmaceuticals Popped: What You Need to Know – The Motley Fool
- Top 6 Stocks for June – NASDAQ
- NPS Pharmaceuticals Shares Popped: What You Need to Know – The Motley Fool
- A Dedication to R&D Means These Stocks Could See Robust Growth – SeekingAlpha
- Squeeze Ideas: 20 Biotech Stocks Targeted by Short Sellers – SeekingAlpha
How do you think NPSP will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
121
Outperform
18
Underperform
All-Star Players
29
Outperform
4
Underperform
Wall Street
7
Outperform
0
Underperform
RSS Headlines
Fool UK
